Medical device procedures

Medicare volume, surgeons, growth, site of care and device makers for 52 device-driven procedures

Compare two markets

Each procedure page adds up the Medicare market across the states MedaRep covers: its growth, where the cases are done, how its surgeons are turning over, which companies engage them and who holds FDA clearances in the category.

  • Largest orthopedic, spine and wound procedures by 2024 Medicare fee-for-service cases: debridement & negative-pressure wound therapy (3,389,687), skin substitutes & wound grafts (504,012), decompression & minimally invasive spine (105,318).
  • Reported by CMS. Fee-for-service alone falls as patients move to Medicare Advantage, so its trend understates the market.
  • Forecast record: one year ahead, MedaRep’s market forecasts have been off by 4% overall, weighted by case volume; each page gives its own procedure’s record.

Growing fastest since 2019

  1. CGM & insulin pump management+22%/yr
  2. Skin substitutes & wound grafts+15%/yr
  3. Aneurysm & intracranial embolization+13%/yr
  4. SI joint fusion+13%/yr
  5. LAA occlusion & loop recorders+10%/yr

Procedures with 2,000+ Medicare cases in both years; yearly growth in Medicare fee-for-service cases.

Strongest outlook to 2030

  1. Tumor & fibroid embolization+15%/yr
  2. EP ablation+11%/yr
  3. Aneurysm & intracranial embolization+11%/yr
  4. CGM & insulin pump management+11%/yr
  5. LAA occlusion & loop recorders+10%/yr

MedaRep's forecast of Medicare fee-for-service cases, for procedures it has forecast within 15% a year ahead.

Moving out of the hospital fastest

  1. Tumor & fibroid embolization+53 pts to 56%
  2. Skin substitutes & wound grafts+31 pts to 70%
  3. Peripheral nerve stimulation & intrathecal pumps+24 pts to 59%
  4. SI joint fusion+21 pts to 45%
  5. Spinal cord & DRG stimulation+19 pts to 60%

Share of surgeons' claims in surgery centers and offices, CMS claim summary.

Most new surgeons since 2021

  1. Skin substitutes & wound grafts1,477 (71%)
  2. CGM & insulin pump management2,855 (42%)
  3. Debridement & negative-pressure wound therapy4,993 (35%)
  4. Sleep apnea & airway implants46 (30%)
  5. Sinus surgery & balloon dilation383 (29%)

Surgeons who started billing it, as a share of today's.

Spine & neurosurgery

ProcedureSurgeonsMedicare FFSGrowth since 2019Out of hospitalForecast
Decompression & minimally invasive spine2,544105,318−5.9%/yr2019: 142666, 2020: 117961, 2021: 119896, 2022: 112710, 2023: 106956, 2024: 105318−5.9%/yr8%112,600 in 2030+1.1%/yr
Lumbar fusion2,35295,082−1.5%/yr2019: 102350, 2020: 90225, 2021: 94613, 2022: 95442, 2023: 94633, 2024: 95082−1.5%/yr2%107,700 in 2030+2.1%/yr
Cervical fusion & disc arthroplasty96247,639−4%/yr2019: 58422, 2020: 50405, 2021: 50362, 2022: 48780, 2023: 49100, 2024: 47639−4%/yr4%52,600 in 2030+1.7%/yr
Kyphoplasty & vertebroplasty45342,837−5.7%/yr2019: 57496, 2020: 45956, 2021: 46107, 2022: 43992, 2023: 43758, 2024: 42837−5.7%/yr32%44,800 in 2030+0.7%/yr
SI joint fusion1477,710+13%/yr2019: 4209, 2020: 4588, 2021: 5746, 2022: 6578, 2023: 6659, 2024: 7710+13%/yr45%14,700 in 2030+11%/yr

Biologics & wound care

ProcedureSurgeonsMedicare FFSGrowth since 2019Out of hospitalForecast
Debridement & negative-pressure wound therapy14,2393,389,687−0.3%/yr2019: 3437454, 2020: 3283322, 2021: 3427818, 2022: 3277467, 2023: 3305792, 2024: 3389687−0.3%/yr44%3,953,800 in 2030+2.6%/yr
Skin substitutes & wound grafts2,068504,012+15%/yr2019: 248246, 2020: 256323, 2021: 295314, 2022: 339800, 2023: 405846, 2024: 504012+15%/yr70%807,400 in 2030+8.2%/yr
Bone graft & orthobiologics54522,075−9.8%/yr2019: 36903, 2020: 30962, 2021: 30343, 2022: 27884, 2023: 24907, 2024: 22075−9.8%/yr2%22,500 in 2030+0.3%/yr

Pain & neuromodulation

ProcedureSurgeonsMedicare FFSGrowth since 2019Out of hospitalForecast
Radiofrequency ablation (facet, genicular, basivertebral)5,025365,4360%/yr2019: 365294, 2020: 346826, 2021: 373425, 2022: 359707, 2023: 350085, 2024: 3654360%/yr78%446,400 in 2030+3.4%/yr
Peripheral nerve stimulation & intrathecal pumps59737,794+7.9%/yr2019: 25822, 2020: 23325, 2021: 28726, 2022: 29325, 2023: 33873, 2024: 37794+7.9%/yr59%64,500 in 2030+9.3%/yr
Spinal cord & DRG stimulation66824,248−3.1%/yr2019: 28431, 2020: 23149, 2021: 23630, 2022: 23783, 2023: 24611, 2024: 24248−3.1%/yr60%28,100 in 2030+2.5%/yr

Vascular & endovascular

ProcedureSurgeonsMedicare FFSGrowth since 2019Out of hospitalForecast
Peripheral arterial intervention1,321182,726−5.9%/yr2019: 247937, 2020: 227278, 2021: 219144, 2022: 204196, 2023: 195375, 2024: 182726−5.9%/yr61%215,300 in 2030+2.8%/yr
Superficial venous ablation1,980166,794−4.1%/yr2019: 205475, 2020: 156379, 2021: 165373, 2022: 161810, 2023: 162506, 2024: 166794−4.1%/yr96%191,600 in 2030+2.3%/yr
Dialysis access1,721161,268−13%/yr2019: 331702, 2020: 299091, 2021: 241308, 2022: 201607, 2023: 177804, 2024: 161268−13%/yr64%158,700 in 2030−0.3%/yr
Thrombectomy, IVC filters & venous stents38947,332+0.1%/yr2019: 47128, 2020: 44990, 2021: 47840, 2022: 46084, 2023: 47216, 2024: 47332+0.1%/yr18%62,700 in 2030+4.8%/yr
Carotid revascularization74136,694−5%/yr2019: 47526, 2020: 38271, 2021: 37806, 2022: 36836, 2023: 36992, 2024: 36694−5%/yr0%40,000 in 2030+1.5%/yr
Aortic endografts (EVAR/TEVAR)8913,204−6.8%/yr2019: 18754, 2020: 14992, 2021: 14860, 2022: 13884, 2023: 13450, 2024: 13204−6.8%/yr0%13,800 in 2030+0.7%/yr

General & bariatric surgery

ProcedureSurgeonsMedicare FFSGrowth since 2019Out of hospitalForecast
Hernia repair2,306187,629−3%/yr2019: 218351, 2020: 180431, 2021: 190469, 2022: 189778, 2023: 189036, 2024: 187629−3%/yr7%210,200 in 2030+1.9%/yr
Cholecystectomy & appendectomy2,560131,995−5.4%/yr2019: 174128, 2020: 145645, 2021: 146379, 2022: 136495, 2023: 133123, 2024: 131995−5.4%/yr2%140,500 in 2030+1%/yr
Colorectal resection23252,254−5.2%/yr2019: 68091, 2020: 58089, 2021: 58220, 2022: 53746, 2023: 53732, 2024: 52254−5.2%/yr0%53,600 in 2030+0.4%/yr
Antireflux & hiatal hernia surgery37523,396−1.8%/yr2019: 25677, 2020: 21305, 2021: 22138, 2022: 22451, 2023: 22880, 2024: 23396−1.8%/yr0%28,800 in 2030+3.5%/yr
Breast reconstruction6613,660−6.4%/yr2019: 19050, 2020: 15465, 2021: 14169, 2022: 13781, 2023: 13710, 2024: 13660−6.4%/yr4%17,400 in 2030+4.1%/yr
Bariatric surgery154,952−17%/yr2019: 12527, 2020: 8795, 2021: 8419, 2022: 8515, 2023: 7005, 2024: 4952−17%/yr0%3,750 in 2030−4.5%/yr

Urology & women's health

ProcedureSurgeonsMedicare FFSGrowth since 2019Out of hospitalForecast
Kidney stone management3,401159,938−1.4%/yr2019: 171443, 2020: 150120, 2021: 158721, 2022: 155663, 2023: 156107, 2024: 159938−1.4%/yr15%172,300 in 2030+1.2%/yr
BPH procedures2,196155,142−6.4%/yr2019: 216166, 2020: 197351, 2021: 218714, 2022: 199225, 2023: 181840, 2024: 155142−6.4%/yr38%148,000 in 2030−0.8%/yr
Hysterectomy, hysteroscopy & ablation90683,637−1.3%/yr2019: 89501, 2020: 73867, 2021: 80972, 2022: 81791, 2023: 83159, 2024: 83637−1.3%/yr16%95,100 in 2030+2.2%/yr
Incontinence, prolapse & sacral neuromodulation1,05873,050−1.4%/yr2019: 78450, 2020: 65374, 2021: 74206, 2022: 72472, 2023: 74314, 2024: 73050−1.4%/yr17%83,900 in 2030+2.3%/yr
Prostatectomy & nephrectomy59237,032−1.1%/yr2019: 39196, 2020: 36319, 2021: 37506, 2022: 37238, 2023: 36370, 2024: 37032−1.1%/yr0%45,600 in 2030+3.5%/yr

ENT & sleep

ProcedureSurgeonsMedicare FFSGrowth since 2019Out of hospitalForecast
Sinus surgery & balloon dilation1,305139,655−2.1%/yr2019: 154921, 2020: 116155, 2021: 120770, 2022: 125665, 2023: 131861, 2024: 139655−2.1%/yr86%173,800 in 2030+3.7%/yr
Ear tubes & middle ear surgery698,303−6.6%/yr2019: 11689, 2020: 7898, 2021: 7661, 2022: 7908, 2023: 8028, 2024: 8303−6.6%/yr48%8,360 in 2030+0.1%/yr
Sleep apnea & airway implants1515,383+26%/yr2022: 3372, 2023: 4910, 2024: 5383+26%/yr5%5,940 in 2030+1.6%/yr
Cochlear implants1143,948+5.5%/yr2019: 3025, 2020: 2390, 2021: 2950, 2022: 3185, 2023: 3621, 2024: 3948+5.5%/yr12%5,240 in 2030+4.8%/yr

Interventional oncology & breast

ProcedureSurgeonsMedicare FFSGrowth since 2019Out of hospitalForecast
Breast biopsy & localization3,675218,500−1.8%/yr2019: 239783, 2020: 209860, 2021: 231889, 2022: 226516, 2023: 224276, 2024: 218500−1.8%/yr29%243,500 in 2030+1.8%/yr
Tumor & fibroid embolization31418,000+6%/yr2019: 13458, 2020: 12752, 2021: 13055, 2022: 13797, 2023: 15161, 2024: 18000+6%/yr56%42,100 in 2030+15%/yr
Tumor ablation638,642+0.4%/yr2019: 8451, 2020: 7696, 2021: 8011, 2022: 8145, 2023: 8423, 2024: 8642+0.4%/yr0%12,000 in 2030+5.6%/yr

Diabetes & referred DME

ProcedureSurgeonsMedicare FFSGrowth since 2019Out of hospitalForecast
CGM & insulin pump management6,808893,092+22%/yr2019: 332345, 2020: 354378, 2023: 734640, 2024: 893092+22%/yr84%1,632,200 in 2030+11%/yr

Cardiac rhythm & electrophysiology

ProcedureSurgeonsMedicare FFSGrowth since 2019Out of hospitalForecast
Pacemaker, ICD & CRT implantation3,039159,222−3.4%/yr2019: 189503, 2020: 166251, 2021: 168745, 2022: 162790, 2023: 162376, 2024: 159222−3.4%/yr3%164,900 in 2030+0.6%/yr
EP ablation2,323129,831+7.2%/yr2019: 91763, 2020: 83429, 2021: 96686, 2022: 102395, 2023: 111392, 2024: 129831+7.2%/yr0%241,600 in 2030+11%/yr
LAA occlusion & loop recorders2,939120,836+10%/yr2019: 74705, 2020: 67700, 2021: 85351, 2022: 97596, 2023: 111334, 2024: 120836+10%/yr18%217,900 in 2030+10%/yr

Interventional & structural cardiology

ProcedureSurgeonsMedicare FFSGrowth since 2019Out of hospitalForecast
Coronary intervention (PCI)5,056218,309−6.5%/yr2019: 305574, 2020: 251483, 2021: 251895, 2022: 230707, 2023: 223943, 2024: 218309−6.5%/yr2%236,300 in 2030+1.3%/yr
Structural heart (TAVR, TEER)2,84963,491+3.8%/yr2019: 52607, 2020: 50824, 2021: 55747, 2022: 57525, 2023: 60389, 2024: 63491+3.8%/yr0%90,800 in 2030+6.2%/yr
Mechanical circulatory support5617,228−4.4%/yr2019: 21570, 2020: 18605, 2021: 18608, 2022: 17276, 2023: 16911, 2024: 17228−4.4%/yr0%19,300 in 2030+1.9%/yr
PFO & septal closure101,097+2.2%/yr2019: 983, 2020: 828, 2021: 945, 2022: 886, 2023: 945, 2024: 1097+2.2%/yr0%1,130 in 2030+0.5%/yr

Neurovascular & neurosurgical devices

ProcedureSurgeonsMedicare FFSGrowth since 2019Out of hospitalForecast
Aneurysm & intracranial embolization39814,006+13%/yr2019: 7576, 2020: 7527, 2021: 9076, 2022: 10083, 2023: 11505, 2024: 14006+13%/yr0%25,900 in 2030+11%/yr
Stroke thrombectomy44612,543+1.7%/yr2019: 11513, 2020: 11257, 2021: 11636, 2022: 11244, 2023: 11965, 2024: 12543+1.7%/yr0%14,600 in 2030+2.5%/yr
DBS & VNS1569,717−3.7%/yr2019: 11756, 2020: 10493, 2021: 11837, 2022: 10194, 2023: 10260, 2024: 9717−3.7%/yr1%14,000 in 2030+6.2%/yr
CSF shunts565,163−4.8%/yr2019: 6589, 2020: 5313, 2021: 5673, 2022: 5465, 2023: 5286, 2024: 5163−4.8%/yr0%6,290 in 2030+3.3%/yr

Ophthalmology

ProcedureSurgeonsMedicare FFSGrowth since 2019Out of hospitalForecast
Cataract & MIGS8,4061,858,437−1.3%/yr2019: 1984872, 2020: 1583259, 2021: 1821988, 2022: 1887986, 2023: 1956661, 2024: 1858437−1.3%/yr83%2,081,700 in 2030+1.9%/yr
Vitreoretinal surgery1,07878,831−3.2%/yr2019: 92662, 2020: 77362, 2021: 82265, 2022: 78762, 2023: 78349, 2024: 78831−3.2%/yr65%82,600 in 2030+0.8%/yr

GI & pulmonary endoscopy

ProcedureSurgeonsMedicare FFSGrowth since 2019Out of hospitalForecast
Colonoscopy & upper endoscopy17,7323,622,736−2.9%/yr2019: 4194248, 2020: 3290937, 2021: 3742272, 2022: 3659964, 2023: 3650404, 2024: 3622736−2.9%/yr46%3,877,600 in 2030+1.1%/yr
ERCP & endoscopic ultrasound1,734112,761−1.2%/yr2019: 119580, 2020: 108023, 2021: 110487, 2022: 105974, 2023: 108349, 2024: 112761−1.2%/yr2%137,600 in 2030+3.4%/yr
Bronchoscopy & lung nodule1,570101,765+4.5%/yr2019: 81506, 2020: 69585, 2021: 73688, 2022: 78269, 2023: 88657, 2024: 101765+4.5%/yr0%172,300 in 2030+9.2%/yr
  • Surgeons and Medicare fee-for-service cases: 2024 figures summed over the states where each procedure tops 100 cases a year.
  • The line: Medicare fee-for-service cases since 2019.
  • Out of hospital: surgeons’ claims in surgery centers and offices in CMS’s latest claim summary.
  • Outlook: MedaRep’s forecast.

Markets by state · Compare two markets · How the numbers are made